CO6940430A2 - Nuevos portadores recubiertos para la liberación controlada de agente activo - Google Patents

Nuevos portadores recubiertos para la liberación controlada de agente activo

Info

Publication number
CO6940430A2
CO6940430A2 CO14093176A CO14093176A CO6940430A2 CO 6940430 A2 CO6940430 A2 CO 6940430A2 CO 14093176 A CO14093176 A CO 14093176A CO 14093176 A CO14093176 A CO 14093176A CO 6940430 A2 CO6940430 A2 CO 6940430A2
Authority
CO
Colombia
Prior art keywords
active agent
controlled release
coated carriers
new coated
new
Prior art date
Application number
CO14093176A
Other languages
English (en)
Spanish (es)
Inventor
Patrick Schwarzentruber
Maiuta Nicola Di
Joachim Schoelkopf
Catherine Jean Ridgway
Patrick A C Gane
Original Assignee
Omya Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47143128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6940430(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP11188597.6A external-priority patent/EP2591772B1/en
Application filed by Omya Int Ag filed Critical Omya Int Ag
Publication of CO6940430A2 publication Critical patent/CO6940430A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28—Microcapsules or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
CO14093176A 2011-11-10 2014-04-30 Nuevos portadores recubiertos para la liberación controlada de agente activo CO6940430A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11188597.6A EP2591772B1 (en) 2011-11-10 2011-11-10 New coated controlled release active agent carriers
US201161559253P 2011-11-14 2011-11-14

Publications (1)

Publication Number Publication Date
CO6940430A2 true CO6940430A2 (es) 2014-05-09

Family

ID=47143128

Family Applications (1)

Application Number Title Priority Date Filing Date
CO14093176A CO6940430A2 (es) 2011-11-10 2014-04-30 Nuevos portadores recubiertos para la liberación controlada de agente activo

Country Status (25)

Country Link
US (1) US9579291B2 (enExample)
EP (1) EP2747752B1 (enExample)
KR (1) KR101612655B1 (enExample)
CN (1) CN103957893B (enExample)
AU (1) AU2012334082B2 (enExample)
BR (1) BR112014011310B1 (enExample)
CA (1) CA2851069C (enExample)
CL (1) CL2014001172A1 (enExample)
CO (1) CO6940430A2 (enExample)
DK (1) DK2747752T3 (enExample)
ES (1) ES2553091T3 (enExample)
IL (1) IL231959A0 (enExample)
IN (1) IN2014MN00843A (enExample)
MX (1) MX346884B (enExample)
MY (1) MY168425A (enExample)
PH (1) PH12014500750A1 (enExample)
PL (1) PL2747752T3 (enExample)
PT (1) PT2747752E (enExample)
RU (2) RU2018123688A (enExample)
SG (1) SG11201401350WA (enExample)
SI (1) SI2747752T1 (enExample)
SM (1) SMT201600010B (enExample)
TW (1) TWI625129B (enExample)
WO (1) WO2013068478A1 (enExample)
ZA (1) ZA201403611B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE025008T2 (en) 2012-10-12 2016-04-28 Omya Int Ag Gastro-reactive pharmaceutical composition and delivery systems and method for their preparation using functionalized calcium carbonate
BR112015019387A2 (pt) * 2013-02-15 2017-07-18 Wellmark Int alimentação mineral - através de formulação
EP3103844B1 (en) * 2015-06-10 2018-08-08 Omya International AG Use of surface-reacted calcium carbonate as anti-blocking agent
EP3176222A1 (en) * 2015-12-01 2017-06-07 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
US11622929B2 (en) 2016-03-08 2023-04-11 Living Proof, Inc. Long lasting cosmetic compositions
EP3275947A1 (en) * 2016-07-25 2018-01-31 Omya International AG Surface-reacted calcium carbonate with functional cations
EP3400810A1 (en) 2017-05-11 2018-11-14 Omya International AG Surface-reacted calcium carbonate in food
CN107258776A (zh) * 2017-06-29 2017-10-20 山东大农药业有限公司 一种缓释农药颗粒剂及其制备方法
US10987300B2 (en) 2017-09-13 2021-04-27 Living Proof, Inc. Long lasting cosmetic compositions
US10842729B2 (en) 2017-09-13 2020-11-24 Living Proof, Inc. Color protectant compositions
WO2019072877A1 (en) 2017-10-10 2019-04-18 Capsugel Belgium Nv GETTING MULTIPARTICULAR COMPOSITIONS
AU2018370210B2 (en) 2017-11-20 2024-09-26 Living Proof, Inc. Properties for achieving long-lasting cosmetic performance
EP3520798A1 (en) * 2018-01-31 2019-08-07 Omya International AG Use of functionalized calcium carbonate as active ingredient
BR112020021902B1 (pt) 2018-04-27 2024-02-20 Living Proof, Inc Composições cosméticas de poliuretano-ureia para tratamento capilar, método de preservação da ondulação no cabelo humano e os usos de poliuretano-ureia
EP3598105A1 (en) 2018-07-20 2020-01-22 Omya International AG Method for detecting phosphate and/or sulphate salts on the surface of a substrate or within a substrate, use of a lwir detecting device and a lwir imaging system
KR102739456B1 (ko) * 2018-10-31 2024-12-09 (주)아모레퍼시픽 바이오 폴리머를 포함하는 코어-쉘 네트워크 구조체 및 이를 포함하는 조성물
WO2020091456A1 (ko) * 2018-10-31 2020-05-07 ㈜아모레퍼시픽 바이오 폴리머를 포함하는 코어-쉘 네트워크 구조체 및 이를 포함하는 조성물
US20220105047A1 (en) * 2019-01-16 2022-04-07 Research Cooperation Foundation Of Yeungnam University Microcapsule composition using alginate gel, and method for producing same
KR102936013B1 (ko) 2019-12-03 2026-03-10 (주)아모레퍼시픽 바이오 폴리머를 포함하는 효능물질 전달체
CN111436426B (zh) * 2020-05-11 2022-04-08 北京首创股份有限公司 供水管道输水用二次加氯胶囊及其制备方法
EP3928859A1 (en) * 2020-06-23 2021-12-29 Omya International AG Surface-reacted calcium carbonate in a process for the production of a loaded microcapsule
AR123009A1 (es) 2020-07-20 2022-10-19 Omya Int Ag Agente estabilizante para composición probiótica
AU2024408252A1 (en) 2023-12-19 2026-08-06 Omya International Ag Granular material comprising a carboxymethylcellulose binder
WO2025207519A1 (en) * 2024-03-23 2025-10-02 Texas Tech University System Biocompatible and biodegradable polymer nanodiscs as lipoprotein-mimicking nanocarriers with high stability and long circulation time for drug delivery
EP4741032A1 (en) 2024-11-07 2026-05-13 Evonik Operations GmbH Performance enhancement of defoamer formulations via a matrix encapsulation strategy

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2223896A1 (de) 1972-05-17 1973-11-29 Sanol Arznei Schwarz Gmbh Verfahren zum ueberziehen von feinteiligen arzneimitteln
US4657784A (en) 1986-03-10 1987-04-14 Ecolab Inc. Process for encapsulating particles with at least two coating layers having different melting points
ES2134796T3 (es) * 1992-12-01 1999-10-16 Spirig Ag Pharmazeutische Prap Composiciones farmaceuticas que contienen s(+)-ibuprofeno.
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2871474B1 (fr) 2004-06-11 2006-09-15 Omya Development Ag Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
EP1891937A1 (en) 2006-08-25 2008-02-27 Novartis AG Galenic formulations of aliskiren
EP1974807B1 (en) * 2007-03-21 2010-03-03 Omya Development Ag Process for the removal of endocrine disrupting compounds
DE602007009124D1 (de) 2007-12-12 2010-10-21 Omya Development Ag Verfahren zur Herstellung von oberflächenreaktives Fällungskalziumkarbonat
EP2168572A1 (en) * 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier
CN102481257B (zh) 2009-04-24 2014-08-13 Omya国际股份公司 用于控释活性成分的颗粒材料
RS52296B (sr) 2009-06-15 2012-12-31 Omya Development Ag Postupak za dobijanje površinski izreagovanog kalcijum karbonata i njegova upotreba
PT2264108E (pt) 2009-06-15 2012-05-23 Omya Development Ag Processo para preparar um carbonato de cálcio feito reagir em superfície utilizando um ácido fraco

Also Published As

Publication number Publication date
NZ623515A (en) 2016-09-30
MX2014005466A (es) 2014-08-22
SMT201600010B (it) 2016-02-25
CL2014001172A1 (es) 2014-09-12
US9579291B2 (en) 2017-02-28
BR112014011310B1 (pt) 2022-04-12
IN2014MN00843A (enExample) 2015-07-03
IL231959A0 (en) 2014-05-28
AU2012334082A1 (en) 2014-04-24
SG11201401350WA (en) 2014-05-29
KR20140091054A (ko) 2014-07-18
KR101612655B1 (ko) 2016-04-14
TW201328709A (zh) 2013-07-16
RU2018123688A (ru) 2019-03-07
DK2747752T3 (en) 2016-01-18
ZA201403611B (en) 2015-07-29
EP2747752B1 (en) 2015-10-07
CA2851069C (en) 2016-05-31
AU2012334082B2 (en) 2015-10-29
ES2553091T3 (es) 2015-12-04
PH12014500750A1 (en) 2014-05-12
CN103957893A (zh) 2014-07-30
SI2747752T1 (sl) 2015-12-31
MY168425A (en) 2018-11-09
CA2851069A1 (en) 2013-05-16
BR112014011310A2 (pt) 2017-05-09
MX346884B (es) 2017-04-05
RU2665382C1 (ru) 2018-08-29
CN103957893B (zh) 2017-08-15
PL2747752T3 (pl) 2016-04-29
RU2018123688A3 (enExample) 2022-01-24
WO2013068478A1 (en) 2013-05-16
EP2747752A1 (en) 2014-07-02
TWI625129B (zh) 2018-06-01
US20140248340A1 (en) 2014-09-04
PT2747752E (pt) 2016-02-08

Similar Documents

Publication Publication Date Title
CY20222200002T2 (el) Βιοαποικοδομησιμα λιπιδια για την απελευθερωση δραστικων παραγοντων
ZA201403611B (en) New coated controlled release active agent carriers
CO6791604A2 (es) Compuesto para liberación controlada de agentes de tratamiento de pozos
BR112013021368A2 (pt) implante, especialmente para oclusão de abeurismas bifurcais
CR20140119A (es) Composición y apósito para tratamiento de heridas
BR112013018679A2 (pt) agente para o tratamento da alopecia
BR112013033444A2 (pt) formulações para terapia de ferida
BR112014004895A2 (pt) oligonucleotídeos antissentido para o tratamento de amaurose congênita de leber
BR112014001441A2 (pt) copolímeros em multi-blocos termoplásticos, de fase separada, semi-cristalinos, biodegradáveis para liberação controlada de compostos biologicamente ativos
CO6801706A2 (es) Método para inhibir o controlar la liberación del agente de tratamiento de pozo
BR112013011744A2 (pt) dispositivos intravaginais para entrega controlada de luibrificantes
EP2790769A4 (en) ANTISEPTIC APPLICATOR
BR112013022411A2 (pt) artigo absorvente e método para preparar um artigo absorvente
EP2790770A4 (en) ANTISEPTIC APPLICATOR
ZA201500137B (en) Dressing having sustained release of active agents
CO6791617A2 (es) Combinaciones de compuestos activos
BR112013030370A2 (pt) compostos de quinona para tratamento de doenças mediadas por ape1
EP2753158A4 (en) FÖRDERBAND
CO6801728A2 (es) Formulación de lipomosas adecuada para tratar o prevenir la tuberculosis
SMT201500235B (it) Formulazione comprendente derivato di fenilamminopirimidina come agente attivo
BR112013031702A2 (pt) 1-piperazino-3-fenil indanos deuterados para o tratamento de esquizofrenia
IL236466B (en) Pharmaceutical composition for the release of active components
HUE050945T2 (hu) Gyógyszerforma hatóanyagok nyújtott felszabadítására
EP2780051A4 (en) NEW IMPROVED FORMULATIONS FOR COATING MEDICAL DEVICES
BR112014003996A2 (pt) polímero, composição e partícula para deposição de um agente de benefício